Episode 10 – Interview with Dr. Sholzberg on COVID coagulopathy

Welcome back Rounds Table Listeners!

This week we interviewed Dr. Michelle Sholzberg to discuss coagulopathy associated with COVID-19.

Dr. Sholzberg is a clinical hematologist with a focus on bleeding and is the Medical Director of the Coagulation Laboratory at St. Michael’s Hospital in Toronto, Ontario, Canada. She is also the Co-Director of the Hematology-Oncology Clinical Research Group and of the Hematology-Immunology Translational Research Theme.

She is Principal Investigator on the RAPID-COVID COAG Study which is randomizing patients hospitalized with COVID-19 who have an elevated d-dimer to review low dose versus therapeutic dose anti-coagulation.

Learn more about the study here: @COVIDtrialsON or by emailing Dr. Sholzberg (Michelle.Sholzberg@unityhealth.to).

Questions? Comments? Feedback? We’d love to hear from you. @roundstable

Leave a Comment

Your email address will not be published. Required fields are marked *

1 Comment
  • Dr. Maha Othman says:

    Excellent discussion and synopsis on COVID coagulopathy + introduction to RAPID COVID RCT. All the best.


Michael Fralick

Co-director of the Rounds Table

Michael Fralick is a general internist at Mount Sinai Hospital in Toronto. He completed a Master of Science in Clinical Epidemiology at Harvard University, including a Research Fellowship in Health Policy at the Program On Regulation Therapeutics and Law (PORTAL). His PhD focused on the intersection between machine learning and pharmacoepidemiology.

John Fralick


John Fralick is a general internist at Foothills Medical Centre in Calgary. He completed a Master of Science in Epidemiology at Queen’s University. He completed medical school at the University of Calgary and did his internal medicine training at the University of Toronto.

Michelle Sholzberg


Republish this article

Republish this article on your website under the creative commons licence.

Learn more